Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects

E-ISSN： 1873-4286|18|19|2702-2712

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.19, 2012-06, pp. : 2702-2712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel targets for VEGF-independent anti-angiogenic drugs

By Petrillo Marco Scambia Giovanni Ferrandina Gabriella

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 451-472

Informa Healthcare

Access to resources Recommend Favorite

Clinical Use of Therapies Targeting Tumor Vasculature and Stroma

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 498-508

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Vasculature: Reality or a Dream?

By Satchi-Fainaro Ronit

Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. : 529-533

Informa Healthcare

Access to resources Recommend Favorite

An update on the clinical development of drugs to disable tumor vasculature

By Siemann Dietmar W Chaplin David J

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1357-1367

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumorangiogenesis in Lung Cancer by Suppression of VEGF and its Receptor - Results from Clinical Trials and Novel Experimental Approaches

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3157-3165

Bentham Science Publishers

Access to resources Recommend Favorite